[1] |
KRIEG A M. CpG motifs in bacterial DNA and their immune effects[J]. Annu Rev Immunol, 2002, 20:709-760.
|
[2] |
BODE C, ZHAO G, STEINHAGEN F, et al. CpG DNA as a vaccine adjuvant[J]. Expert Rev Vaccines, 2011, 10(4):499-511.
|
[3] |
KLINMAN D M, KLASCHIK S, SATO T, et al. CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases[J]. Adv Drug Deliv Rev, 2009, 61(3):248-255.
|
[4] |
ZHANG L H, TIAN X S, ZHOU F Z. Vaccination with Newcastle disease vaccine and CpG oligodeoxynucleotides induces specific immunity and protection against Newcastle disease virus in SPF chicken[J]. Vet Immunol Immunopathol, 2007, 115(3-4):216-222.
|
[5] |
ZHAO Z J, HE R X, CHU P P, et al. YBX has functional roles in CpG-ODN against cold stress and bacterial infection of Misgurnus anguillicaudatus[J]. Fish Shellfish Immunol, 2021, 118:72-84.
|
[6] |
CAI H M, WEI J T, SHEN H K, et al. Molecular cloning, characterization and expression profiles of Annexin family (ANXA1-A6) in yellow catfish (Pelteobagrus fulvidraco) and ANX regulation by CpG ODN responding to bacterial infection[J]. Fish Shellfish Immunol, 2020, 99:609-630.
|
[7] |
RICHMOND P, HATCHUEL L, DONG M, et al. Safety and immunogenicity of S-Trimer (SCB-2019), a protein subunit vaccine candidate for COVID-19 in healthy adults:a phase 1, randomised, double-blind, placebo-controlled trial[J]. Lancet, 2021, 397(10275):682-694.
|
[8] |
GARDINER IV J H, KOMAZIN G, MATSUO M, et al. Lipoprotein N-acylation in Staphylococcus aureus is catalyzed by a two-component acyl transferase system[J]. mBio, 2020, 11(4):e01619-20.
|
[9] |
朱关平, 童乐民, 汪家芳, 等. 分枝杆菌和珊瑚红球菌细胞壁成分的免疫特性[J]. 抗生素, 1984(3):259.ZHU G P, TONG L M, WANG J F, et al. Immunological properties of CWs from BCG and rhodococcus corallina[J]. Chinese Journal Of Antibiotics, 1984(3):259. (in Chinese)
|
[10] |
张祝兰, 连云阳, 严凌斌, 等. 一种赤红球菌提取物的用途:中国, 110101721A[P]. 2019-08-09.ZHANG Z L, LIAN Y Y, YAN L B, et al. The utility model relates to an extract of red coccus:CN, 110101721A[P]. 2019-08-09. (in Chinese)
|
[11] |
格雷厄姆·麦金太尔, 约翰·L·斯坦福, 辛西娅·A·斯坦福, 等. 作为免疫调节物的全细菌细胞:英国, 1735431B[P]. 2006-02-15.GRAHAM M I, JOHN L S, CYNTHIA A S, et al. An entire bacterial cell serving as an immunomodulator:UK, 1735431B[P]. 2006-02-15. (in Chinese)
|
[12] |
付家栋. 一种赤红球菌发酵方法及其作为佐剂在动物疫苗中的应用:中国, 109666609A[P]. 2019-04-23.FU J D. The invention relates to a method of red coccus fermentation and application of red coccus fermentation as an adjuvant in animal vaccine:CN, 109666609A[P]. 2019-04-23. (in Chinese)
|
[13] |
严悌昆, 张毓金, 陈 珊, 等. 一种红色红球菌免疫增强剂及其在猪用疫苗中的应用:中国, 113975383A[P]. 2022-01-28.YAN T K, ZHANG Y J, CHEN S, et al. The invention relates to an immunopotentiator of rhodococcus rubra and application thereof in swine vaccines:CN, 13975383A[P]. 2022-01-28. (in Chinese)
|
[14] |
SØRENSEN L N, REINERT L S, MALMGAARD L, et al. TLR2 and TLR9 synergistically control herpes simplex virus infection in the brain[J]. J Immunol, 2008, 181(12):8604-8612.
|
[15] |
THAISS C A, LEVY M, ITAV S, et al. Integration of innate immune signaling[J]. Trends Immunol, 2016, 37(2):84-101.
|
[16] |
TURSI S A, LEE E Y, MEDEIROS N J, et al. Bacterial amyloid curli acts as a carrier for DNA to elicit an autoimmune response via TLR2 and TLR9[J]. PLoS Pathog, 2017, 13(4):e1006315.
|
[17] |
LAI C Y, YU G Y, LUO Y P, et al. Immunostimulatory activities of CpG-Oligodeoxynucleotides in teleosts:toll-like receptors 9 and 21[J]. Front Immunol, 2019, 10:179.
|
[18] |
CHUANG Y C, TSENG J C, YANG J X, et al. Toll-like receptor 21 of chicken and duck recognize a broad array of immunostimulatory CpG-oligodeoxynucleotide sequences[J]. Vaccines (Basel), 2020, 8(4):639.
|
[19] |
SAIF Y M, BARNES H J, GLISSON J R. 禽病学[M]. 11版. 苏敬良, 高 福, 索 勋, 译. 北京:中国农业出版社, 2005.SAIF Y M, BARNES H J, GLISSON J R. Diseases of poultry[M]. 11th ed. SU J L, GAO F, SUO X, trans. Beijing:China Agriculture Press, 2005. (in Chinese)
|
[20] |
刘元杰, 张 媛, 王秀丽, 等. 新型动物疫苗佐剂的研究进展[J]. 中国兽药杂志, 2021, 55(2):74-80.LIU Y J, ZHANG Y, WANG X L, et al. Research progress of new animal vaccine adjuvants[J]. Chinese Journal of Veterinary Drug, 2021, 55(2):74-80. (in Chinese)
|
[21] |
曾 振, 王海宁, 张志芳, 等. 新型疫苗佐剂的研究进展[J]. 生物工程学报, 2021, 37(1):78-87.ZENG Z, WANG H N, ZHANG Z F, et al. Research progress of new vaccine adjuvants[J]. Chinese Journal of Biotechnology, 2021, 37(1):78-87. (in Chinese)
|
[22] |
ZHANG S X, CAI H M, CAO D, et al. Recombinant plasmids containing CpG with porcine host defense peptides (PR-39/pBD-1) modulates the innate and adaptive intestinal immune responses (including maternal-derived) in piglets[J]. Int Immunopharmacol, 2019, 70:467-476.
|
[23] |
詹少春, 孙 超, 廖 想. 一株赤红球菌及其作为免疫佐剂在制备疫苗中的应用:中国, 109576180A[P]. 2019-04-05.ZHAN S C, SUN C, LIAO X. A strain of rhodococcus and its application as an immune adjuvant in preparation of vaccine:CN, 109576180A[P]. 2019-04-05. (in Chinese)
|
[24] |
PEDERSEN J C. Hemagglutination-inhibition assay for influenza virus subtype identification and the detection and quantitation of serum antibodies to influenza virus[M]//SPACKMAN E. Animal Influenza Virus. New York:Springer, 2014:11-25.
|
[25] |
LIVAK K J, SCHMITTGEN T D. Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method[J]. Methods, 2001, 25(4):402-408.
|
[26] |
张英楠, 张桂山, 徐 晶, 等. 基于TLR2/4-NF-κB信号通路研究刺五加多糖对鸡淋巴细胞的调节作用[J]. 中国兽医杂志, 2021, 57(7):94-99.ZHANG Y N, ZHANG G S, XU J, et al. Study of regulatory effects of Acanthopanax senticosus polysaccharide on TLR2/4-NF-κB signaling pathway in chicken lymphocytes[J]. Chinese Journal of Veterinary Medicine, 2021, 57(7):94-99. (in Chinese)
|
[27] |
马占邦, 许丽文, 王芳芳, 等. 不同来源传染性支气管炎病毒诱导SPF鸡发病的免疫机制研究[J]. 中国畜牧兽医, 2021, 48(12):4628-4640.MA Z B, XU L W, WANG F F, et al. Effects of different origins of infectious bronchitis virus on immune function in SPF chicken[J]. China Animal Husbandry & Veterinary Medicine, 2021, 48(12):4628-4640. (in Chinese)
|
[28] |
董长贵, 何桂梅, 乔 健, 等. 鸡IL-12的基因克隆与序列分析[J]. 中国兽医杂志, 2007, 43(10):22-23.DONG C G, HE G M, QIAO J, et al. Cloning and sequencing of the chicken interleukin-12 genes[J]. Chinese Journal of Veterinary Medicine, 2007, 43(10):22-23. (in Chinese)
|
[29] |
CAO W P, MISHINA M, AMOAH S, et al. Nasal delivery of H5N1 avian influenza vaccine formulated with GenJetTM or in vivo-jetPEI® induces enhanced serological, cellular and protective immune responses[J]. Drug Deliv, 2018, 25(1):773-779.
|
[30] |
IBRAHIM Z A, ARMOUR C L, PHIPPS S, et al. RAGE and TLRs:relatives, friends or neighbours?[J]. Mol Immunol, 2013, 56(4):739-744.
|
[31] |
RANASINGHE C, RAMSHAW I A. Genetic heterologous prime-boost vaccination strategies for improved systemic and mucosal immunity[J]. Expert Rev Vaccines, 2009, 8(9):1171-1181.
|
[32] |
杨同涛, 孙法良, 崔京腾, 等. 一例白羽肉鸡H9N2禽流感的分离鉴定[J]. 北方牧业, 2019(20):28.YANG T T, SUN F L, CUI J T, et al. Isolation and identification of H9N2 avian influenza virus in a white-feathered broiler[J]. BeiFang MuYe, 2019(20):28. (in Chinese)
|
[33] |
HIAM-GALVEZ K J, ALLEN B M, SPITZER M H. Systemic immunity in cancer[J]. Nat Rev Cancer, 2021, 21(6):345-359.
|
[34] |
BRONTE V, PITTET M J. The spleen in local and systemic regulation of immunity[J]. Immunity, 2013, 39(5):806-818.
|
[35] |
沈 双, 高 明. 常用禽流感疫苗利弊分析[J]. 特种经济动植物, 2022, 25(3):106-107.SHEN S, GAO M. Analysis of advantages and disadvantages of avian influenza vaccine[J]. Special Economic Animals and Plants, 2022, 25(3):106-107. (in Chinese)
|
[36] |
陈生雷, 王一平, 谷崇高, 等. 免疫佐剂对禽流感疫苗抗体的影响评价[J]. 现代畜牧兽医, 2021(12):63-65.CHEN S L, WANG Y P, GU C G, et al. Evaluation of the effect of immune adjuvant on avian influenza vaccine antibody[J]. Modern Journal of Animal Husbandry and Veterinary Medicine, 2021(12):63-65. (in Chinese)
|
[37] |
SCHEIERMANN J, KLINMAN D M. Clinical evaluation of CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases and cancer[J]. Vaccine, 2014, 32(48):6377-6389.
|
[38] |
LURIE N, SAVILLE M, HATCHETT R, et al. Developing Covid-19 vaccines at pandemic speed[J]. N Engl J Med, 2020, 382(21):1969-1973.
|